 您的位置：对照品 > 标准品 > dr标准品 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：C781455 |
| 产品名称：CPI-444 |
| 产品CAS：1202402-40-1 |
| 规格含量：25mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
C781455 |
| 名称: |
CPI-444 |
| 别名: |
(S)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine; Triazolo-pyramidine Derivative; |
| CAS号: |
1202402-40-1 |
| 分子式: |
C₂₀H₂₁N₇O₃ |
| 外观: |
白色至淡黄色固体 |
| 熔点: |
169-171°C |
| 分子量: |
407.43 |
| 储存: |
Amber Vial, -20°C Freezer, Under inert atmosphere |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly) |
| 类别: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: |
CPI-444 is an orally administered antagonist to the A2A receptor, and binds to adenosine receptors on the surface of immune cells. |
| 参考文献 |
|
|
|
|
|
|
